Takeda, a Japanese company, announced its financial results today. The Company's press release confirmed that its second-generation dengue vaccine QDENGA® (TAK-003) remains unavailable in the United States.
In July 2023, Takeda announced that it voluntarily withdrew the Biologics License Application for TAK-003, following discussions with the U.S. Food and Drug Administration on aspects of data collection that could not be addressed within the current review cycle.
Second-Gen Dengue Vaccine Remains Unavailable in the U.S.
DogBot Explains Which Dogs Can Fly to the United States
While rabies was officially eliminated in dogs in the United States in 2007, unvaccinated canines can still contract the deadly disease from rabid wildlife, including bats.
If you plan on bringing a dog into the U.S. this summer, new rules from the government may impact your plans.
The U.S. Centers for Disease Control and Prevention (CDC) announced on May 8, 2024, new dog importation rules will be implemented in August 2024.